Detailansicht

Wissensnetz

Person

Charlotte Niemeyer (1954-)

Ärztin

Name	Charlotte Niemeyer
Zeit	1954- (Lebensdaten)
Ort	Freiburg im Breisgau (Wirkungsort) Deutschland
Geschlecht	weiblich
Beruf	Ärztin (charakteristischer Beruf) Hochschullehrerin
Variante	Charlotte M. Niemeyer
Beziehung	Deutsche Akademie der Naturforscher Leopoldina (Mitglied, Matrikelnummer 07376) (2010-)
Themengebiet	Personen zu Medizin, Tiermedizin
Weitere Angaben	Prof. in Freiburg
Quelle	Landesbibliographie Baden-Württemberg
Datensatztyp	Person
GND-Nummer	1012787621
Datensatz-ID	1012787621
Beteiligt an alle anzeigen Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography Case report: Lomustine overdose in a 15-year-old, healthy adolescent—a prescription failure Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia Ren(n), wenn du kannst! : Architektur und psychosoziale Gesundheit schwerkranker Kinder und Jugendlicher sowie ihrer Eltern im Krankenhaus Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia Development of MDS in pediatric patients with GATA2 deficiency: increased histone trimethylation and deregulated apoptosis as potential drivers of transformation Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape OC 34 - Onco-fetal programming drives high-risk juvenile myelomonocytic leukemia, which can be targeted by anti-CD52 treatment [Abstract] Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants Abnormal B-cell maturation and increased transitional B cells in CBL syndrome Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma Comprehensive analyses of coagulation parameters in patients with vascular anomalies Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS CircRNAs dysregulated in juvenile myelomonocytic leukemia: CircMCTP1 stands out Current treatment of juvenile myelomonocytic leukemia Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature Efficacy of sirolimus in patients requiring tracheostomy for life-threatening lymphatic malformation of the head and neck: a report from the european reference network Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia Prevalence of SARS-CoV-2 infection in children and their parents in Southwest Germany Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial Association of country-specific socioeconomic factors with survival of patients who experience severe classic acute graft-vs.-host disease after allogeneic hematopoietic cell transplantation : : an analysis from the transplant complications working party of the EBMT Case report: hepatic adenoma in a child with a congenital extrahepatic portosystemic shunt Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation TIM‐3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis‐like T‐cell lymphoma and hemophagocytic lymphohistiocytosis Impaired human hematopoiesis due to a cryptic intronic GATA1 splicing mutation THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents THROMBOTECT: a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents Author Correction: The landscape of genomic alterations across childhood cancers GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML Pädiatrische Hämatologie und Onkologie Pädiatrische Hämatologie und Onkologie Recurring mutations in RPL15 are linked to hydrops fetalis and treatment independence in Diamond-Blackfan anemia The landscape of genomic alterations across childhood cancers The landscape of genomic alterations across childhood cancers THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms Clinical and molecular heterogeneity of RTEL1 deficiency

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Charlotte Niemeyer (1954-)

Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography

Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup

Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography

Case report: Lomustine overdose in a 15-year-old, healthy adolescent—a prescription failure

Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial

Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia

Ren(n), wenn du kannst! : Architektur und psychosoziale Gesundheit schwerkranker Kinder und Jugendlicher sowie ihrer Eltern im Krankenhaus

Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

Development of MDS in pediatric patients with GATA2 deficiency: increased histone trimethylation and deregulated apoptosis as potential drivers of transformation

Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape

OC 34 - Onco-fetal programming drives high-risk juvenile myelomonocytic leukemia, which can be targeted by anti-CD52 treatment [Abstract]

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis

Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants

Abnormal B-cell maturation and increased transitional B cells in CBL syndrome

Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma

Comprehensive analyses of coagulation parameters in patients with vascular anomalies

Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants

Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML

Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

CircRNAs dysregulated in juvenile myelomonocytic leukemia: CircMCTP1 stands out

Current treatment of juvenile myelomonocytic leukemia

Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature

Efficacy of sirolimus in patients requiring tracheostomy for life-threatening lymphatic malformation of the head and neck: a report from the european reference network

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

Prevalence of SARS-CoV-2 infection in children and their parents in Southwest Germany

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

Association of country-specific socioeconomic factors with survival of patients who experience severe classic acute graft-vs.-host disease after allogeneic hematopoietic cell transplantation : : an analysis from the transplant complications working party of the EBMT

Case report: hepatic adenoma in a child with a congenital extrahepatic portosystemic shunt

Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

TIM‐3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis‐like T‐cell lymphoma and hemophagocytic lymphohistiocytosis

Impaired human hematopoiesis due to a cryptic intronic GATA1 splicing mutation

THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

THROMBOTECT: a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

Author Correction: The landscape of genomic alterations across childhood cancers

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML

Pädiatrische Hämatologie und Onkologie

Pädiatrische Hämatologie und Onkologie

Recurring mutations in RPL15 are linked to hydrops fetalis and treatment independence in Diamond-Blackfan anemia

The landscape of genomic alterations across childhood cancers

The landscape of genomic alterations across childhood cancers

THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents

Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms

Clinical and molecular heterogeneity of RTEL1 deficiency